Skip to main content

Matthias Gromeier

Cless Family Distinguished Professor in Neuro-Oncology
Neurosurgery, Neuro-Oncology
Box 3020 Med Ctr, Durham, NC 27710
Research Drive, Rm 423, MSRB1, Durham, NC 27710
Office hours N/A  

Overview


I am a classically trained virologist with a focus on molecular mechanisms of RNA virus pathogenesis. My career is dedicated to unraveling RNA virus:host relations and devising methods of exploiting them for cancer immunotherapy and vaccine design. My background is in translation regulation and mRNA metabolism, viral RNA sensing and innate immunity, and cancer immunology and immunotherapy. Basic mechanistic research in my laboratory is supporting an ambitious clinical translational research program with active multi-center clinical trials in several cancer indications.

Current Appointments & Affiliations


Cless Family Distinguished Professor in Neuro-Oncology · 2023 - Present Neurosurgery, Neuro-Oncology, Neurosurgery
Professor of Neurosurgery · 2016 - Present Neurosurgery, Neuro-Oncology, Neurosurgery
Professor in Medicine · 2016 - Present Medicine, Infectious Diseases, Medicine
Professor in Molecular Genetics and Microbiology · 2016 - Present Molecular Genetics and Microbiology, Basic Science Departments
Professor of Cell Biology · 2022 - Present Cell Biology, Basic Science Departments
Member of the Duke Cancer Institute · 1999 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published May 4, 2023
Duke Awards 44 Distinguished Professorships
Published January 31, 2020
Poliovirus Therapy Shows Potential as Cancer Vaccine in Lab Studies
Published September 20, 2017
Poliovirus Therapy Induces Immune Responses Against Cancer

View All News

Recent Publications


Polio virotherapy provokes MDA5 signaling and CD4+ T cell help to mediate cancer in situ vaccination.

Journal Article Microbiol Mol Biol Rev · September 25, 2025 SUMMARYThere is overwhelming evidence that antitumor CD8+ T cell responses can mediate effective tumor control. CD8+ T cell responses are quintessential defensive measures directed against categorically intracellular pathogens. It is thus intuitively obvio ... Full text Link to item Cite

Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma.

Journal Article Transl Oncol · February 2024 HSV G207, a double-stranded, DNA virus, and the polio:rhinovirus chimera, PVSRIPO, a single positive-strand RNA virus, are viral immunotherapies being used to treat pediatric malignant brain tumors in clinical trials. The purpose of this work is to elucida ... Full text Link to item Cite

Early enterovirus translation deficits extend viral RNA replication and elicit sustained MDA5-directed innate signaling.

Journal Article mBio · December 19, 2023 Multiple pattern recognition receptors sense vRNAs and initiate downstream innate signaling: endosomal Toll-like receptors (TLRs) 3, 7, and 8 and cytoplasmic RIG-I-like receptors (RLRs) RIG-I, and MDA5. They engage distinct signaling scaffolds: mitochondri ... Full text Link to item Cite
View All Publications

Recent Grants


Pharmacological Sciences Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030

Duke Research Training Program in Surgical Oncology

Inst. Training Prgm or CMEMentor · Awarded by National Cancer Institute · 2024 - 2029

Innate Antiviral Signals for Cancer Immunotherapy

ResearchPrincipal Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2018 - 2028

View All Grants

Education, Training & Certifications


University of Hamburg (Germany) · 1992 M.D.

External Links


Gromeier Lab